To include your compound in the COVID-19 Resource Center, submit it here.

Endocyte soars on MAA plans

Endocyte Inc. (NASDAQ:ECYT) gained $2.39 (25%) to $11.88 on Tuesday after announcing plans to submit applications

Read the full 164 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE